BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Zhou X, Hu B. The "reversibility" of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgrad Med 2022. [PMID: 35382697 DOI: 10.1080/00325481.2022.2063604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Mou Y, Hu B. Discussion on the common controversies of Helicobacter pylori infection. Helicobacter 2023;28:e12938. [PMID: 36436202 DOI: 10.1111/hel.12938] [Reference Citation Analysis]
2 Yu Z, Sheng WD, Yin X, Bin Y. Coptis, Pinellia, and Scutellaria as a promising new drug combination for treatment of Helicobacter pylori infection . World J Clin Cases 2022; 10(34): 12500-12514 [DOI: 10.12998/wjcc.v10.i34.12500] [Reference Citation Analysis]
3 Yang H, Guan L, Hu B, Moreira L. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022;2022:1-10. [DOI: 10.1155/2022/4710964] [Reference Citation Analysis]
4 Chang C, Feng W, Sun M, Yu X, Sun Z, Tang M. Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations. Computational and Mathematical Methods in Medicine 2022;2022:1-13. [DOI: 10.1155/2022/4237040] [Reference Citation Analysis]